RBC Capital Markets acted as Co-Manager for a $1.725 billion Senior Convertible Notes offering for Hologic, Inc.

Transaction Information In December 2007, Hologic, Inc. priced $1.725 billion in a single tranche of convertible senior notes to repay the $1.25 billion outstanding under its 18-months senior secured capital markets term loan facility that was part of the Cytyc acquisition financing. Excess net proceeds resulting from the offering will be used to pay down a portion of the Company's senior secured tranche B term loan facility. The transaction launched after market close on December 3, 2007 and was upsized from $1.3 billion. RBC Capital Markets acted as Co-Manager for this transaction. About Hologic Hologic, Inc. is a diversified medical technologies company specializing in diagnostic, imaging products and interventional devices dedicated to serving the healthcare needs of women. Historically, the Company has developed, manufactured and marketed products focused on

mammography, breast care and osteoporosis assessment. In October 2007, Hologic completed its business combination with Cytyc Corporation, a company that develops, manufactures and markets complementary products covering a range of cancers and women's health indications, including cervical cancer screening, treatment of excessive menstrual bleeding, prenatal diagnostics and partial breast radiation therapy.

Summary Terms

Convertible Notes Offering

Offering Size:	$1.725 billion Senior Notes
Coupon:	2.00% per annum
Conversion Premium:	25%
Term:	30 Years (maturing in 2037)

Investment Banking Contact

Kevin Davies
Managing Director

Co-Head, U.S. Healthcare
212-428-6617
kevin.davies@rbccm.com